Tanase, D.M.; Radu, S.; Al Shurbaji, S.; Baroi, G.L.; Florida Costea, C.; Turliuc, M.D.; Ouatu, A.; Floria, M.
Natriuretic Peptides in Heart Failure with Preserved Left Ventricular Ejection Fraction: From Molecular Evidences to Clinical Implications. Int. J. Mol. Sci. 2019, 20, 2629.
https://doi.org/10.3390/ijms20112629
AMA Style
Tanase DM, Radu S, Al Shurbaji S, Baroi GL, Florida Costea C, Turliuc MD, Ouatu A, Floria M.
Natriuretic Peptides in Heart Failure with Preserved Left Ventricular Ejection Fraction: From Molecular Evidences to Clinical Implications. International Journal of Molecular Sciences. 2019; 20(11):2629.
https://doi.org/10.3390/ijms20112629
Chicago/Turabian Style
Tanase, Daniela Maria, Smaranda Radu, Sinziana Al Shurbaji, Genoveva Livia Baroi, Claudia Florida Costea, Mihaela Dana Turliuc, Anca Ouatu, and Mariana Floria.
2019. "Natriuretic Peptides in Heart Failure with Preserved Left Ventricular Ejection Fraction: From Molecular Evidences to Clinical Implications" International Journal of Molecular Sciences 20, no. 11: 2629.
https://doi.org/10.3390/ijms20112629
APA Style
Tanase, D. M., Radu, S., Al Shurbaji, S., Baroi, G. L., Florida Costea, C., Turliuc, M. D., Ouatu, A., & Floria, M.
(2019). Natriuretic Peptides in Heart Failure with Preserved Left Ventricular Ejection Fraction: From Molecular Evidences to Clinical Implications. International Journal of Molecular Sciences, 20(11), 2629.
https://doi.org/10.3390/ijms20112629